Related Experiment Videos
Crow-Fukase syndrome
Abstract:
Crow-Fukase syndrome is a unique multisystem disorder that is also known as POEMS syndrome (an acronym for polyneuropathy, organomegaly, endocrinopathy, the presence of M-protein and skin change). This syndrome is strongly associated with plasma cell dyscrasia. Circulating light chains of M component, almost invariably IgG lambda or IgA lambda, are found in 75% of patients. Neuropathologically, segmental demyelination, particularly in the proximal segment of the peripheral nerve trunk, is the primary process. Axonal degeneration and marked endoneurial edema are also characteristic. Focal excessive myelin outfolds with globular features corresponding to periodicity and paranodal enlargement of myelin are also highly characteristic of this syndrome. Vascular endothelial growth factor (VEGF) was found to be specifically and highly elevated in the serum of patients with this syndrome, suggesting a pathogenic role. M-protein, interleukin (IL)-1beta, IL-6 and tumor necrosis factor (TNF)-alpha are also considered to be involved in the pathogenesis. Treatment consists of radiation and surgical resection of the myeloma, chemotherapy, and a high dose of intravenous immunoglobulin (IVIg).
Insights
Crow-Fukase syndrome, also known as POEMS syndrome, is a multisystem disorder linked to plasma cell issues. Elevated vascular endothelial growth factor (VEGF) suggests a key role in its development.
Area of Science:
- Neurology
- Oncology
- Immunology
Background:
- Crow-Fukase syndrome, or POEMS syndrome, is a rare multisystem disorder.
- It is characterized by polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes.
- The condition is strongly associated with plasma cell dyscrasia.
Purpose of the Study:
- To summarize the key pathological and etiological features of Crow-Fukase (POEMS) syndrome.
- To highlight the role of specific biomarkers and pathological findings.
- To outline current treatment strategies.
Main Methods:
- Review of neuropathological findings, including segmental demyelination and endoneurial edema.
- Analysis of serological markers, particularly vascular endothelial growth factor (VEGF).
- Identification of associated M-protein and cytokine profiles (IL-1beta, IL-6, TNF-alpha).
Main Results:
- Neuropathology reveals segmental demyelination, axonal degeneration, and endoneurial edema.
- Focal excessive myelin outfolds and paranodal enlargement are characteristic.
- Elevated serum VEGF levels are specifically noted, suggesting a pathogenic role.
- M-protein (IgG lambda or IgA lambda) is present in 75% of patients.
Conclusions:
- Crow-Fukase (POEMS) syndrome is a distinct entity with specific neuropathological hallmarks.
- Elevated VEGF is a key pathogenic factor.
- Treatment involves addressing the underlying plasma cell disorder and managing symptoms, including IVIg.